MACKENZIE FINANCIAL CORP
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 919859
TORONTO ONTARIO, A6
Position in ALNY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,241,707
+$5,794,816 QoQ
Shares Held
43,988
+95.4% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#161
of 764 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $497,470,026 across 59 Biotechnology names. ALNY ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
135,783 | $84,666,131 | |
| 2 | INCY |
Incyte Corp
|
634,862 | $71,967,956 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
931,864 | $53,321,258 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102,928 | $51,127,425 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
298,440 | $22,227,811 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
985,848 | $16,759,416 | |
| 7 | RPRX |
Royalty Pharma plc
|
270,457 | $15,164,523 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
43,988 | $13,241,707 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,241,707 | 43,988 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,446,891 | 22,507 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,928,871 | 12,395 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $4,456,488 | 9,773 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,959,266 | 9,075 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,561,139 | 9,485 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $2,084,611 | 8,859 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $5,415,615 | 19,691 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $8,770,113 | 36,091 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,767,066 | 18,515 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,892,513 | 20,336 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $3,851,216 | 21,746 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $5,716,434 | 30,096 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $5,167,655 | 25,797 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $5,992,820 | 25,217 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,706,562 | 23,514 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $3,063,725 | 21,006 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $3,163,907 | 19,376 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,952,557 | 17,411 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,955,820 | 15,655 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,159,684 | 12,740 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $1,565,655 | 11,089 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,233,155 | 9,488 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,442,459 | 9,907 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,523,498 | 17,038 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $396,649 | 3,644 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||